Skip to main content

Cognition

3
Pipeline Programs
13
Companies
10
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

11 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
0,5 mg FingolimodPhase 41 trial
Active Trials
NCT02575365Terminated4Est. Jan 2017
Astellas
AstellasChina - Shenyang
1 program
1
SolifenacinPhase 41 trial
Active Trials
NCT01126424Completed26Est. Dec 2010
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
AZD1446Phase 11 trial
Active Trials
NCT01044342Completed20Est. Apr 2010
GSK
GSKLONDON, United Kingdom
2 programs
Beverage powder fortified with micronutrients and Bacopa monnieri extractN/A
Test beverage powderN/A
ViiV Healthcare
ViiV HealthcareNC - Durham
2 programs
Beverage powder fortified with micronutrients and Bacopa monnieri extractN/A1 trial
Test beverage powderN/A1 trial
Active Trials
NCT02416245Completed310Est. Mar 2015
NCT02177942Completed528Est. Jun 2015
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Behavioral measuresN/A1 trial
Active Trials
NCT01212029Completed159Est. Oct 2024
Cognition Therapeutics
Cognition TherapeuticsPA - Pittsburgh
1 program
Beverage powder fortified with micronutrients and Bacopa monnieri extractN/A
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Decision-making taskN/A1 trial
Active Trials
NCT07606469Not Yet Recruiting30Est. Jun 2028
Lumos Pharma
Lumos PharmaTX - Austin
1 program
Digital Program 1N/A1 trial
Active Trials
NCT05912556Active Not Recruiting816Est. May 2025
Young BioPharma
Young BioPharmaMA - Lowell
1 program
Neuropsychological TestingN/A1 trial
Active Trials
NCT00188331Completed441Est. Sep 2015
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
adaptive cognitive trainingN/A1 trial
Active Trials
NCT06524388Enrolling By Invitation120Est. Jun 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Sandoz0,5 mg Fingolimod
AstellasSolifenacin
AstraZenecaAZD1446
Colorado TherapeuticsDecision-making task
UNION therapeuticsadaptive cognitive training
Lumos PharmaDigital Program 1
ViiV HealthcareBeverage powder fortified with micronutrients and Bacopa monnieri extract
ViiV HealthcareTest beverage powder
Human BioSciencesBehavioral measures
Young BioPharmaNeuropsychological Testing

Clinical Trials (10)

Total enrollment: 2,454 patients across 10 trials

NCT02575365Sandoz0,5 mg Fingolimod

Effect of Fingolimod on Neurodegeneration

Start: Feb 2016Est. completion: Jan 20174 patients
Phase 4Terminated
NCT01126424AstellasSolifenacin

A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability

Start: Apr 2010Est. completion: Dec 201026 patients
Phase 4Completed
NCT01044342AstraZenecaAZD1446

A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition

Start: Dec 2009Est. completion: Apr 201020 patients
Phase 1Completed
NCT07606469Colorado TherapeuticsDecision-making task

Human Neural Correlates of Multi-Timescale Inference

Start: Jun 2026Est. completion: Jun 202830 patients
N/ANot Yet Recruiting
NCT06524388UNION therapeuticsadaptive cognitive training

Adaptive Cognitive Training on Cognitive Function in Elderly Diabetes Patients in the Community

Start: Oct 2024Est. completion: Jun 2027120 patients
N/AEnrolling By Invitation
NCT05912556Lumos PharmaDigital Program 1

Brain Response to an Intervention Using Guided, At-Home Technology for the Mind

Start: Jul 2023Est. completion: May 2025816 patients
N/AActive Not Recruiting
NCT02416245ViiV HealthcareBeverage powder fortified with micronutrients and Bacopa monnieri extract

Impact of Beverage Powder With Micronutrients and Brahmi Extract on Cognitive Variables in Indian School Children

Start: Jul 2014Est. completion: Mar 2015310 patients
N/ACompleted
NCT02177942ViiV HealthcareTest beverage powder

A Clinical Trial to Study the Impact of a Nutritional Beverage on Tests of Memory in Healthy Preschool Age Children

Start: Jun 2014Est. completion: Jun 2015528 patients
N/ACompleted
NCT01212029Human BioSciencesBehavioral measures

Testing and Calibration of Non-Invasive Optical Imaging Technology for Functional Brain Imaging

Start: Sep 2011Est. completion: Oct 2024159 patients
N/ACompleted
NCT00188331Young BioPharmaNeuropsychological Testing

Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy

Start: Nov 2003Est. completion: Sep 2015441 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

13 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.